ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 68 filers reported holding ADC THERAPEUTICS SA in Q3 2022. The put-call ratio across all filers is 2.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,845,631 | -79.8% | 5,402,041 | -51.6% | 1.54% | -57.3% |
| Q2 2023 | $24,010,770 | +278.0% | 11,167,800 | +242.8% | 3.60% | +19.5% |
| Q1 2023 | $6,351,852 | +257.0% | 3,257,360 | +603.1% | 3.01% | +210.4% |
| Q4 2022 | $1,779,110 | +49.0% | 463,310 | +87.1% | 0.97% | +51.6% |
| Q3 2022 | $1,194,000 | – | 247,630 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $24,681,000 | 9.63% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $22,288,000 | 4.35% |
| Redmile Group, LLC | 7,432,429 | $109,182,000 | 3.41% |
| MPM BioImpact LLC | 334,384 | $4,912,000 | 1.32% |
| Indie Asset Partners, LLC | 96,572 | $1,419,000 | 1.07% |
| Eventide Asset Management | 1,975,000 | $29,013,000 | 0.46% |
| HHLR ADVISORS, LTD. | 500,000 | $7,345,000 | 0.15% |
| Virtus ETF Advisers LLC | 19,193 | $282,000 | 0.13% |
| Walleye Capital LLC | 248,354 | $3,648,000 | 0.10% |
| Matrix Capital Management Company, LP | 400,000 | $5,876,000 | 0.07% |